Analyst ratings and price target adjustments are significant indicators of a stock's short-term performance. JP Morgan's downgrade from Overweight to Neutral and the reduction in price target from $58 to $57 suggest a less optimistic outlook on Corteva's stock, likely leading to a decrease in investor confidence and a short-term negative impact on the stock price.